Category Archives: Cancer Treatment

Clay Siegall – the President of Seattle Genetics

According to Clay Siegall’s interview with the ideamensch, the primary focus of Seattle Genetics is to help patients who are in need. He even confesses of watching his father died out of cancer. Since then the primary goal of Mr. Clay Siegall is to treat patients who are suffering from cancer and do it better than it was done before. He is excited to make cancer patients smile again.

As an entrepreneur, Clay Siegall’s states that at age 20 most of the entrepreneurs think they know everything. But when they reach thirty, they realized that they do not know very much. Therefore, Mr. Clay’s advice to young entrepreneurs is that they should learn as much as they can. This can be achieved through interaction with smart people and experts in the area of interest.

As a business person, Mr. Clay Siegall believe in collaboration as one of the critical business strategies. He prefers collaborating with innovators in the oncology drug development and industry leaders. Through collaboration, Seattle Genetics has extended its reach to better technology, and the available resources have been converted to new ideas and approaches that can help in improving the status of cancer patients.

About Dr. Clay Siegall

Dr. Clay Siegall is the CEO, Chairman, President, and co-founder of Seattle Genetics. By being a scientist, Dr. Clay established Seattle Genetics on the foundation of drug development practice, rigorous research, passion for helping patients, and scientific innovation. His talent has guided the company to its current leadership position in the development ADCs (Antibody-drug conjugates). It is because of Dr. Clay leadership role that led to the approval of the ADC first product, which is ADCETRIS®. The product was approved in 2011 by the FDA.

Before he establishes his company, Dr. Clay Worked with a Pharmaceutical Research Institute known as Bristol-Myers Squibb. This was from 1991 to 1997. He also worked with National Institute of health and National Cancer Institute from 1988 to 1991. Concerning educational background, Clay Siegall attended the University of Maryland, from where he received a Bachelor of Science in Zoology. Dr. Clay also earned his Ph.D. in Genetics from the University of George Washington.